GSK Urges Filtration Of Pentostam In Drug Alert
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline is revising the Summary of Product Characteristics for its anti-parasitic Pentostam in the U.K. to recommend that new and existing batches be filtered prior to administration